Cell and Gene Therapy CDMO Market Size to be Worth USD 29.49 Billion by 2035; Growth is Driven by Increasing Number of Advanced Therapies Globally

U.S. Cell and Gene Therapy CDMO Market is projected to grow from USD 2.09 Billion in 2025 to USD 10.28 Billion by 2035 due to expanding gene and cell therapy pipelines globallyAustin, March 06, 2026 ...
Labroots

Expanding the Cell Painting Tool Kit: Optimizing Imaging Across Diverse and Challenging Cell Lines

Cell painting has established itself as a powerful tool for high content imaging, able to generate vast quantities of data in response to chemical perturbations. Over the past decade, cell painting ...
WGRZ

Roswell Park is expanding cell therapy and research space, looking to the future of cancer treatment

BUFFALO, N.Y. — Flashing a smile for cameras at Roswell Park is 5-year-old superstar Chasity. "You all good?” Chasity kisses her dad Cariorl. Snuggled between her mom Shawanda. “Thank you," he said.
Science Daily

Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists in the Perelman School ...
GEN

Cellares and Technology Provider Team Plan to Expand Cell Q’s Capabilities for Commercial Scale Cell Therapy QC

Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell Q™, a fully automated quality control ...
The Business Journals

Philadelphia region's ever-expanding cell and gene therapy family tree featured in new promotional reel

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Philadelphia-area cell and gene ...
The American Journal of Managed Care

Expanding CAR T-Cell Access With Broader Criteria and Real-World Data: Clark Alsfeld, MD

At the Institute for Value-Based Medicine ® event in New Orleans, Louisiana, on November 4, Clark Alsfeld, MD, a hematology and oncology specialist at Ochsner MD Anderson, spoke about the availability ...